Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)Matthias Preusser, Wolfgang Wick, Petter Brandal et al.|Neuro-Oncology|2021Cited by 81
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomasAgustí Alentorn, Marie‐Pierre Chenard, Caroline Dehais et al.|Neurology|2015Cited by 43
CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDYBrigitta G. Baumert, Roger Stupp, Monika E. Hegi et al.|Neuro-Oncology|2024Cited by 4